β-Blockade in adriamycin-induced cardiomyopathy
- 30 June 2000
- journal article
- research article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 6 (2), 115-119
- https://doi.org/10.1016/s1071-9164(00)90013-7
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Adriamycin cardiomyopathy: pathophysiology and preventionThe FASEB Journal, 1997
- Combination therapy with probucol prevents adriamycin-induced cardiomyopathyJournal of Molecular and Cellular Cardiology, 1995
- Subcellular effects of adriamycin in the heart: A concise reviewJournal of Molecular and Cellular Cardiology, 1987
- Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivoBritish Journal of Cancer, 1986
- Serum lipid peroxides in rats treated chronically with adriamycinBiochemical Pharmacology, 1984
- Mediation of Subacute Anthracycline Cardiotoxicity in Rabbits by Cardiac Histamine ReleaseJournal of Cardiovascular Pharmacology, 1983
- Acute and Chronic Cardiovascular Effects of Doxorubicin in the DogJournal of Cardiovascular Pharmacology, 1980
- Enzymatic Defenses of the Mouse Heart Against Reactive Oxygen MetabolitesJCI Insight, 1980
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977
- A clinicopathologic analysis of adriamycin cardiotoxicityCancer, 1973